These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 7439523

  • 1. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite.
    Borgna JL, Rochefort H.
    Mol Cell Endocrinol; 1980 Oct; 20(1):71-85. PubMed ID: 7439523
    [Abstract] [Full Text] [Related]

  • 2. Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues.
    Borgna JL, Rochefort H.
    J Biol Chem; 1981 Jan 25; 256(2):859-68. PubMed ID: 7451477
    [Abstract] [Full Text] [Related]

  • 3. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ, Nelson K, van Nagell JR, Donaldson ES, Walden ML, Gallion H, Kenady DE.
    Endocrinology; 1987 Apr 25; 120(4):1608-14. PubMed ID: 3830064
    [Abstract] [Full Text] [Related]

  • 4. Similarities and differences of the binding of estradiol and 4-hydroxytamoxifen (an antiestrogen) in the chick oviduct cytosol.
    Geynet C, Shyamala G, Baulieu EE.
    Biochim Biophys Acta; 1983 Apr 20; 756(3):349-53. PubMed ID: 6830859
    [Abstract] [Full Text] [Related]

  • 5. Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA.
    Anolik JH, Klinge CM, Bambara RA, Hilf R.
    J Steroid Biochem Mol Biol; 1993 Dec 20; 46(6):713-30. PubMed ID: 8274405
    [Abstract] [Full Text] [Related]

  • 6. High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor.
    Capony F, Rochefort H.
    Mol Cell Endocrinol; 1978 Dec 20; 11(2):181-98. PubMed ID: 680340
    [Abstract] [Full Text] [Related]

  • 7. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL, Scali J.
    J Steroid Biochem; 1988 Oct 20; 31(4A):427-36. PubMed ID: 3050278
    [Abstract] [Full Text] [Related]

  • 8. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M, Greene G, Rochefort H, Jensen EV.
    Endocrinology; 1982 Apr 20; 110(4):1355-61. PubMed ID: 7060530
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B, Happe HK.
    Endocrinology; 1986 Aug 20; 119(2):904-15. PubMed ID: 3732150
    [Abstract] [Full Text] [Related]

  • 10. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.
    Klinge CM, Traish AM, Bambara RA, Hilf R.
    J Steroid Biochem Mol Biol; 1996 Jan 20; 57(1-2):51-66. PubMed ID: 8645617
    [Abstract] [Full Text] [Related]

  • 11. Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro.
    Klinge CM, Traish AM, Driscoll MD, Hilf R, Bambara RA.
    Steroids; 1996 May 20; 61(5):278-89. PubMed ID: 8738832
    [Abstract] [Full Text] [Related]

  • 12. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
    Keene JL, Ruh MF, Ruh TS.
    J Steroid Biochem; 1984 Dec 20; 21(6):625-31. PubMed ID: 6527530
    [Abstract] [Full Text] [Related]

  • 13. Estrogen-receptor--DNA interaction. Difference between activation by estrogen and antiestrogen.
    Evans E, Baskevitch PP, Rochefort H.
    Eur J Biochem; 1982 Nov 20; 128(1):185-91. PubMed ID: 7173202
    [Abstract] [Full Text] [Related]

  • 14. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand.
    Anolik JH, Klinge CM, Hilf R, Bambara RA.
    Biochemistry; 1995 Feb 28; 34(8):2511-20. PubMed ID: 7873531
    [Abstract] [Full Text] [Related]

  • 15. Multiple estrogen binding sites in the uterus: stereochemistry of receptor and non-receptor binding of diethylstilbestrol and its metabolites.
    Chae K, Johnston SH, Korach KS.
    J Steroid Biochem Mol Biol; 1991 Jan 28; 38(1):35-42. PubMed ID: 1997122
    [Abstract] [Full Text] [Related]

  • 16. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements.
    Klinge CM, Studinski-Jones AL, Kulakosky PC, Bambara RA, Hilf R.
    Mol Cell Endocrinol; 1998 Aug 25; 143(1-2):79-90. PubMed ID: 9806352
    [Abstract] [Full Text] [Related]

  • 17. Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands.
    Pavlik EJ, Nelson K, van Nagell JR, Donaldson ES, Walden ML, Hanson MB, Gallion H, Flanigan RC, Kenady DE.
    Biochemistry; 1985 Dec 31; 24(27):8101-6. PubMed ID: 4092059
    [Abstract] [Full Text] [Related]

  • 18. Physicochemical and genetic evidence for specific antiestrogen binding sites.
    Faye JC, Jozan S, Redeuilh G, Baulieu EE, Bayard F.
    Proc Natl Acad Sci U S A; 1983 Jun 31; 80(11):3158-62. PubMed ID: 6574477
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of the estrogen receptor interaction with 4-hydroxytamoxifen.
    Sasson S, Notides AC.
    Mol Endocrinol; 1988 Apr 31; 2(4):307-12. PubMed ID: 3380103
    [Abstract] [Full Text] [Related]

  • 20. Differences between oestrogen receptor activation by oestrogen and antioestrogen.
    Rochefort H, Borgna JL.
    Nature; 1981 Jul 16; 292(5820):257-9. PubMed ID: 7254318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.